Abstract
Background: Efficient colon-specific drug delivery has been demonstrated recently in the treatment of various diseases, including Crohn's disease, ulcerative colitis (inflammatory bowel disease), and colorectal cancer.
Methods: Of all strategies, the conjugation of a model drug to a carrier (with or without spacers) has been recognized as promising for targeting the colon.
Results: This is because the conjugation method releases large amounts of the drug while reducing the amount of the drug released in the stomach and small intestine.
Conclusion: This review focuses on the design of linkage conjugates that carry out specific delivery to the colon. The types of conjugation for application in colorectal cancer therapy will be discussed as well.
Keywords: Colon-specific delivery, conjugate, colorectal cancer, linkage conjugates, drug delivery, targeting.
Graphical Abstract
Current Drug Metabolism
Title:Conjugation Strategies for Colonic Delivery and its Application in Colorectal Cancer Therapy
Volume: 18 Issue: 11
Author(s): Phuong H.L. Tran, Wei Duan and Thao T.D. Tran*
Affiliation:
- Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City,Vietnam
Keywords: Colon-specific delivery, conjugate, colorectal cancer, linkage conjugates, drug delivery, targeting.
Abstract: Background: Efficient colon-specific drug delivery has been demonstrated recently in the treatment of various diseases, including Crohn's disease, ulcerative colitis (inflammatory bowel disease), and colorectal cancer.
Methods: Of all strategies, the conjugation of a model drug to a carrier (with or without spacers) has been recognized as promising for targeting the colon.
Results: This is because the conjugation method releases large amounts of the drug while reducing the amount of the drug released in the stomach and small intestine.
Conclusion: This review focuses on the design of linkage conjugates that carry out specific delivery to the colon. The types of conjugation for application in colorectal cancer therapy will be discussed as well.
Export Options
About this article
Cite this article as:
Tran H.L. Phuong , Duan Wei and Tran T.D. Thao *, Conjugation Strategies for Colonic Delivery and its Application in Colorectal Cancer Therapy, Current Drug Metabolism 2017; 18 (11) . https://dx.doi.org/10.2174/1389200218666171031150001
DOI https://dx.doi.org/10.2174/1389200218666171031150001 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chitosan: A Propitious Biopolymer for Drug Delivery
Current Drug Delivery MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic
Current Gene Therapy Star Graphs of Protein Sequences and Proteome Mass Spectra in Cancer Prediction
Current Proteomics p42.3: An Abductor of Cell Cycle
Anti-Cancer Agents in Medicinal Chemistry Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Current Pediatric Reviews Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020)
Current Medicinal Chemistry Phenolic Compounds as Nutraceuticals or Functional Food Ingredients
Current Pharmaceutical Design Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Medicinal Chemistry Role of Netrin-1 Beyond the Brain: From Biomarker of Tissue Injury to Therapy for Inflammatory Diseases
Recent Patents on Biomarkers A Comparison of the Anti-Cancer Effects of Free and PLGA-PAA Encapsulated Hydroxytyrosol on the HT-29 Colorectal Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Paeonol, a Powerful Natural Product with Broad Biological Spectra by Inhibiting Inflammatory Pathway
Current Traditional Medicine Using Compound Similarity and Functional Domain Composition for Prediction of Drug-Target Interaction Networks
Medicinal Chemistry Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology Review: Circulating microRNAs in Predicting the Prognosis of Gastrointestinal Cancers
Current Biomarkers (Discontinued) Enzyme-responsive Nanoparticles for Anticancer Drug Delivery
Current Nanoscience Tumor Stroma as a Target in Cancer
Current Cancer Drug Targets Natural Cyclic Peptides as Clinical and Future Therapeutics
Current Organic Chemistry Development of a Novel Reporter Gene Vector for Cell Based Angiogenic Studies
Combinatorial Chemistry & High Throughput Screening MicroRNA Regulatory Network in Human Colorectal Cancer
Mini-Reviews in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery